Skip to main content
OpenTrials

Clinical trial condition

Oropharyngeal Squamous Cell Carcinoma

Explore clinical trials studying Oropharyngeal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

43 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Oropharyngeal Squamous Cell Carcinoma trial results

Active, not recruiting

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

NCT03952585

Conditions
Basaloid Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 494 locations
View Trial Details
Active, not recruiting

Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

NCT03410615

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • University Hospital of Antwerp Edegem, Belgium
  • University Hospital of Gent Ghent, Belgium
  • University Hospital Leuven Leuven, Belgium
View all 26 locations
View Trial Details
Active, not recruiting

Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)

NCT06009861

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations
  • Peking University School and Hospital Stomatology Beijing, Beijing Municipality, China
  • Affiliated Hospital of Hebei University Baoding, Hebei, China
  • Tangshan People's Hospital Tangshan, Hebei, China
  • The First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
View all 13 locations
View Trial Details
Completed

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT03258554

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 256 locations
View Trial Details

Related conditions